Clinical Trial Update: Study of CM518D1 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of CM518D1 in patients with solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CM518D1

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING